Nevertheless, studies in human MDSCs found that both CD11b+CD15+HLA-DRlow/– G-MDSCs and CD11b+CD14+HLA-DRlow/– M-MDSCs can upregulate ROS production in response to tumour-conditioned-supernatant and suppressed T cell proliferation in vitro [77]. Here, CD14 is linked to neoplasm.